Kenneth T. Mills
2020
In 2020, Kenneth T. Mills earned a total compensation of $7.6M as President and CEO at Regenxbio, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $368,042 |
|---|---|
| Option Awards | $6,646,254 |
| Salary | $613,403 |
| Other | $16,388 |
| Total | $7,644,087 |
Mills received $6.6M in option awards, accounting for 87% of the total pay in 2020.
Mills also received $368K in non-equity incentive plan, $613.4K in salary and $16.4K in other compensation.
Rankings
In 2020, Kenneth T. Mills' compensation ranked 1,231st out of 13,090 executives tracked by ExecPay. In other words, Mills earned more than 90.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,231 out of 13,090 | 91st |
Division Manufacturing | 439 out of 5,620 | 92nd |
Major group Chemicals And Allied Products | 152 out of 2,253 | 93rd |
Industry group Drugs | 132 out of 1,953 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 37 out of 411 | 91st |
Source: SEC filing on April 7, 2022.
Mills' colleagues
We found four more compensation records of executives who worked with Kenneth T. Mills at Regenxbio in 2020.